Feedback / Questions
izalontamab brengitecan (BL-B01D1) - Biokin Pharma, BMS
https://www.bms.com/assets/bms/us/en-us/pdf/investor-info/doc_presentations/2025/BMY-2025-Q1-Results-Investor-Presentation-with-Appendix.pdf
Apr 24, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next